How to make the most of integrated commercialization solutions
For pharmaceutical companies, bringing a new therapy to market can be a long and expensive journey. Research and development alone can cost $2.6 billion, on average, and can take several years. Yet, developing a quality product and getting it approved for distribution is not enough to guarantee commercial success.
A new product’s success can rarely be attributed to just one thing, such as good branding or quality patient support services, although both of these are important. Rather, success depends upon the many strategic decisions manufacturers make at different stages along the road to commercialization. The choices manufacturers make in the early planning and development stages impact a product’s commercial success as much as their choices after its launch.
Read the article from AmerisourceBergen which outlines key considerations for manufacturers during each stage of the commercialization process.
By selecting the “yes” option when filling out the above form, you agree to have your contact information passed along for the purpose of following up on your interests and in order to receive communications regarding Illumina products, services, and events. The data sent will be processed in Canada and provided to Illumina who will assume responsibility for processing and opt-out and information removal. Once your information has been processed by Illumina, communication preferences and opt-out can be managed directly on the Illumina website. For more information, please refer to the Illumina privacy policy.